No CrossRef data available.
Published online by Cambridge University Press: 15 April 2020
In patients suffering from borderline personality disorder (BPD) primarily psychotherapeutic care is indicated. Pharmacotherapy is considered as adjuvant and often controversial way of treatment.
Demonstration of pharmacological approach to BPD patients in Olomouc Czech Republic and compare with treatment guidelines. treatment guidelines.
The aim of our study was to compare treatment of BPD patients in 2007 and 2011
The paper examines the state in 2007 and 2011 in BPD patients at the Department of Psychiatry, University Hospital. Our study included outpatients and inpatients treated in all departments. Inclusion criteria were diagnosis BPD. Medication was assessed according to the documentation at discharge or during outpatient care according to the transcript record.
In most cases are BPD patients treated according to current guidelines. The treatment consists of SSRI antidepressants, anticonvulsants and second-generation of antipsychotics. Problem can be considered in some cases with medication dosage, combination, administration of benzodiazepine anxiolytics, hypnotics.
BPD patients are treated according to current recommendations. Inpatients are more medicated than outpatients. The reason is probably in relation with the severity of the symptoms. Medication did not differ from the majority of best practices. But with a lack of strong evidence about its effect, it seems appropriate to move towards its reduction. Supported by the project IGA MZ CR NT 11047-4/2010
Comments
No Comments have been published for this article.